A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment
- Authors
- Kim, Si Eun; Woo, Sookyoung; Kim, Seon Woo; Chin, Juhee; Kim, Hee Jin; Lee, Byung In; Park, Jinse; Park, Kyung Won; Kang, Do-Young; Noh, Young; Ye, Byoung Seok; Yoo, Han Soo; Lee, Jin San; Kim, Yeshin; Kim, Seung Joo; Cho, Soo Hyun; Na, Duk L.; Lockhart, Samuel N.; Jang, Hyemin; Seo, Sang Won
- Issue Date
- Oct-2018
- Publisher
- IOS PRESS
- Keywords
- Amnestic mild cognitive impairment; amyloid PET positivity; neuropsychological tests; nomogram; prediction
- Citation
- JOURNAL OF ALZHEIMERS DISEASE, v.66, no.2, pp.681 - 691
- Journal Title
- JOURNAL OF ALZHEIMERS DISEASE
- Volume
- 66
- Number
- 2
- Start Page
- 681
- End Page
- 691
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5297
- DOI
- 10.3233/JAD-180048
- ISSN
- 1387-2877
- Abstract
- Background: Most clinical trials focus on amyloid-beta positive (A beta+) amnestic mild cognitive impairment (aMCI), but screening failures are high because only a half of patients with aMCI are positive on A beta PET. Therefore, it becomes necessary for clinicians to predict which patients will have A beta biomarker. Objective: We aimed to compare clinical factors, neuropsychological (NP) profiles, and apolipoprotein E (APOE) genotype between A beta+ aMCI and A beta- aMCI and to develop a clinically useful prediction model of A beta positivity on PET (PET-A beta) in aMCI using a nomogram. Methods: We recruited 523 aMCI patients who underwent A beta PET imaging in a nation-wide multicenter cohort. The results of NP measures were divided into following subgroups: 1) Stage (Early and Late-stage), 2) Modality (Visual, Verbal, and Both), 3) Recognition failure, and 4) Multiplicity (Single and Multiple). A nomogram for PET-A beta+ in aMCI patients was constructed using a logistic regression model. Results: PET-A beta+ had significant associations with NP profiles for several items, including high Clinical Dementia Rating Scale Sum of Boxes score (OR 1.47, p= 0.013) and impaired memory modality (impaired both visual and verbal memories compared with visual only, OR 3.25, p =0.001). Also, presence of APOE epsilon 4 (OR 4.14, p <0.001) was associated with PET-A beta+. These predictors were applied to develop the nomogram, which showed good prediction performance (C-statistics = 0.79). Its prediction performances were 0.77/0.74 in internal/external validation. Conclusions: The nomogram consisting of NP profiles, especially memory domain, and APOE epsilon 4 genotype may provide a useful predictive model of PET-A beta+ in patients with aMCI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5297)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.